PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALB vs. WST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALB and WST is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

ALB vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

2,000.00%4,000.00%6,000.00%8,000.00%NovemberDecember2025FebruaryMarchApril
1,462.57%
5,439.97%
ALB
WST

Key characteristics

Sharpe Ratio

ALB:

-0.89

WST:

-0.82

Sortino Ratio

ALB:

-1.31

WST:

-0.87

Omega Ratio

ALB:

0.85

WST:

0.82

Calmar Ratio

ALB:

-0.59

WST:

-0.75

Martin Ratio

ALB:

-1.53

WST:

-1.83

Ulcer Index

ALB:

30.40%

WST:

23.55%

Daily Std Dev

ALB:

52.44%

WST:

52.88%

Max Drawdown

ALB:

-78.91%

WST:

-57.43%

Current Drawdown

ALB:

-78.91%

WST:

-52.97%

Fundamentals

Market Cap

ALB:

$7.82B

WST:

$15.90B

EPS

ALB:

-$11.20

WST:

$6.69

PEG Ratio

ALB:

0.99

WST:

3.77

Total Revenue (TTM)

ALB:

$4.02B

WST:

$2.20B

Gross Profit (TTM)

ALB:

$23.60M

WST:

$769.60M

EBITDA (TTM)

ALB:

-$1.00B

WST:

$578.60M

Returns By Period

In the year-to-date period, ALB achieves a -22.31% return, which is significantly higher than WST's -32.80% return. Over the past 10 years, ALB has underperformed WST with an annualized return of 3.36%, while WST has yielded a comparatively higher 15.18% annualized return.


ALB

YTD

-22.31%

1M

-7.33%

6M

-28.81%

1Y

-47.47%

5Y*

5.95%

10Y*

3.36%

WST

YTD

-32.80%

1M

-2.48%

6M

-25.92%

1Y

-43.04%

5Y*

8.05%

10Y*

15.18%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALB vs. WST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALB
The Risk-Adjusted Performance Rank of ALB is 1313
Overall Rank
The Sharpe Ratio Rank of ALB is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of ALB is 1010
Sortino Ratio Rank
The Omega Ratio Rank of ALB is 1414
Omega Ratio Rank
The Calmar Ratio Rank of ALB is 1818
Calmar Ratio Rank
The Martin Ratio Rank of ALB is 1111
Martin Ratio Rank

WST
The Risk-Adjusted Performance Rank of WST is 1111
Overall Rank
The Sharpe Ratio Rank of WST is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of WST is 1818
Sortino Ratio Rank
The Omega Ratio Rank of WST is 1010
Omega Ratio Rank
The Calmar Ratio Rank of WST is 99
Calmar Ratio Rank
The Martin Ratio Rank of WST is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALB vs. WST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ALB, currently valued at -0.89, compared to the broader market-2.00-1.000.001.002.003.00
ALB: -0.89
WST: -0.82
The chart of Sortino ratio for ALB, currently valued at -1.31, compared to the broader market-6.00-4.00-2.000.002.004.00
ALB: -1.31
WST: -0.87
The chart of Omega ratio for ALB, currently valued at 0.85, compared to the broader market0.501.001.502.00
ALB: 0.85
WST: 0.82
The chart of Calmar ratio for ALB, currently valued at -0.59, compared to the broader market0.001.002.003.004.005.00
ALB: -0.59
WST: -0.75
The chart of Martin ratio for ALB, currently valued at -1.53, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
ALB: -1.53
WST: -1.83

The current ALB Sharpe Ratio is -0.89, which is comparable to the WST Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of ALB and WST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.80-0.60-0.40-0.200.00NovemberDecember2025FebruaryMarchApril
-0.89
-0.82
ALB
WST

Dividends

ALB vs. WST - Dividend Comparison

ALB's dividend yield for the trailing twelve months is around 2.43%, more than WST's 0.37% yield.


TTM20242023202220212020201920182017201620152014
ALB
Albemarle Corporation
2.43%1.87%1.11%0.73%0.67%1.04%2.02%1.74%1.00%1.42%2.07%1.83%
WST
West Pharmaceutical Services, Inc.
0.37%0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%

Drawdowns

ALB vs. WST - Drawdown Comparison

The maximum ALB drawdown since its inception was -78.91%, which is greater than WST's maximum drawdown of -57.43%. Use the drawdown chart below to compare losses from any high point for ALB and WST. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%NovemberDecember2025FebruaryMarchApril
-78.91%
-52.97%
ALB
WST

Volatility

ALB vs. WST - Volatility Comparison

Albemarle Corporation (ALB) has a higher volatility of 13.84% compared to West Pharmaceutical Services, Inc. (WST) at 7.24%. This indicates that ALB's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%NovemberDecember2025FebruaryMarchApril
13.84%
7.24%
ALB
WST

Financials

ALB vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Albemarle Corporation and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab